长期鼻炎与鼻息肉:杜皮卢马布在混合内型的有效性
Giancarlo Pecorari1, Anastasia Urbanelli1, Marco Garetto1
1Division of Otorhinolaryngology, Department of Surgical Sciences, University of Turin, Turin, Italy.
The Laryngoscope
|August 26, 2025
概括
杜皮卢马布有效治疗具有鼻息肉的慢性鼻鼻炎 (CRSwNP),包括混合内型. 在治疗期间鼻子中性粒细胞增加的患者表现出较少的症状和更好的生活质量.
科学领域:
- 免疫学
- 耳鼻喉科
- 肺病学
背景情况:
- 带有鼻息肉的慢性鼻炎 (CRSwNP) 是一种复杂的疾病,具有多种炎症特征,包括混合T2和中性友的内型.
- 了解这些内型对于有效的治疗策略至关重要.
研究的目的:
- 在不同鼻腔内型的CRSwNP患者中评估dupilumab的实际有效性.
- 根据炎症特征进行治疗结果比较.
主要方法:
- 在31名用dupilumab治疗的CRSwNP患者中进行的前性观察研究.
- 评估包括内镜检查,鼻腔细胞检查,嗅觉功能 (VAS),血红素,生活质量 (SNOT-22) 和喘控制 (ACT) 在基线和3,6,12个月.
主要成果:
- 在基线51. 6%的患者中出现了中性粒细胞- 氨基粒细胞的混合内型.
- 在3个月后,不论初始内型,中性粒细胞透率都在51. 6%的患者增加.
- 中性粒细胞增加的患者最初SNOT-22和VAS得分的改善较小,但在12个月后达到相似水平.
结论:
- 杜皮卢马布在CRSwNP中表现出有效性,包括混合的中性粒细胞和氨基粒细胞内型.
- 在dupilumab治疗期间鼻子中性粒细胞增加的部分患者表现出明显的临床特征,改善了生活质量和症状减轻.
相关概念视频
Drugs Used in Lower Respiratory Disorders: Overview
578
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
578
Drugs Used in Upper Respiratory Disorders: Overview
358
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
358
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
453
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
453
Upper Respiratory Drugs: Decongestants
374
Decongestants are a class of medications used primarily to alleviate nasal congestion, a common symptom resulting from allergies, colds, sinusitis, and other upper respiratory tract infections. These drugs work by activating α-adrenergic receptors, constricting small blood vessels in the nasal membranes. This action results in the opening of clogged nasal passages, thereby facilitating sinus drainage and relieving congestion.
Most decongestants are readily available over-the-counter in...
Most decongestants are readily available over-the-counter in...
374
COPD: Management Using Bronchodilators and Corticosteroids
307
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
307


